Biotechnology Analyst, CFA. Cancer, Autoimmune and Neurodegenerative Diseases. Audaces fortuna iuvat.
Joined April 2009
- Tweets 7,899
- Following 579
- Followers 1,607
- Likes 79
2,290 Photos and videos
Full Length Version.
Join Lexaria Bioscience CEO Rich Christopher for a review of the company's GLP-1 agonist studies, business development activities & future opportunities for oral drug development.
$LEXX
youtu.be/GtFIPq0IReo
#OralGLP1 #LexariaBioscience #LexariaDelivery #NextGenDrugDelivery #OralDeliveryTech #OralPeptideDelivery #GLP1Therapy #GLP1Agonist #GLP1Innovation #PeptideTherapeutics #MetabolicTherapy
48
Jun 8
See our note today on @RNAoncology's (TransCode Therapeutics) focus: RNA Therapeutics.
$RNAZ
Zacks_SCR_Research_06082026_RNAZ_Vandermosten_note.pdf
Jun 8
@RNAoncology (TransCode Therapeutics) to host R&D webcast on June 18
*10 am ET
*To feature TTX-MC138, $RNAZ' lead antagomiR program
*KOLs & executives participating
*Webcast link on website
finance.yahoo.com/sectors/he…
1
3
176
Jun 5
CEO Richard Christopher outlines several of @LexariaBioCorp's business development activities that seek partners who want to leverage DehydraTECH’s delivery performance.
$LEXX
#OralGLP1 #GLP1Agonist #GLP1Innovation #PeptideTherapeutics #MetabolicTherapy
youtube.com/shorts/iJresCKRt…
2
2
236
Jun 2
Cardiff Oncology provides updated data for the $CRDF-004 trial noting continued safety & deep & durable tumor shrinkage. Presented data @ASCO & will have KOL event tomorrow for analysts.
$CRDF
finance.yahoo.com/sectors/he…
3
5
921
Jun 2
Cardiff Oncology to present at the Jefferies Global Healthcare conference
*2-4Jun
*1x1 meeting
*CEO in fireside chat
*NYC
$CRDF
finance.yahoo.com/sectors/he…
2
3
279
Jun 2
Get prepped for this event by reviewing our recent initiation on Nasus Pharma.
$NSRX
youtube.com/shorts/Skwn_7QBJ…
Jun 2
Nasus Pharma to hold KOL event on 10Jun to discuss NS002 & anaphylaxis
*Featuring Michael S. Blaiss, MD
*Joel Brooks, DO, MPH
$NSRX
finance.yahoo.com/sectors/he…
1
4
223
Jun 2
Nasus Pharma to hold KOL event on 10Jun to discuss NS002 & anaphylaxis
*Featuring Michael S. Blaiss, MD
*Joel Brooks, DO, MPH
$NSRX
finance.yahoo.com/sectors/he…
1
4
541
Jun 1
See our full-length discussions with @syndevrx CEO Brad Carver & CBO James Shanahan.
#evexomostat #metabo-oncology #MetAP2_inhibitor
#BioPharma #EmergingBiotech #ClinicalResearch #LifeSciences
youtu.be/vljU9CrGAwc
1
2
147
Jun 1
See our extended interview with @RevivaPharma's CEO Dr Bhat. #brilaroxazine #schizophrenia
$RVPH
youtu.be/euVZhOVrtdg
3
5
674
Jun 1
Cardiff Oncology files 8-K reporting Nerviano has terminated its licensing agreement & alleges that $CRDF has failed to use reasonable efforts to develop onvansertib. $CRDF responded asserting the termination is legally ineffective.
investors.cardiffoncology.co…
2
2
4
552
May 29
Zacks SCR initiates on Nasus Pharma with a $19 valuation. The company is developing an inhaled powder form of epinephrine that addresses shortcomings of approved treatments.
$NSRX
#ClinicalTrials #BiotechInvesting
Access our initiation below:
s27.q4cdn.com/906368049/file…
youtube.com/shorts/Skwn_7QBJ…
2
4
158
May 28
Cancer is comprised of many facets and requires a treatment approach that mirrors this. Evexomostat plans to move forward in combination with other modalities such as alpelisib, fulvestrant and chemotherapy. @syndevrx CBO Jim Shanahan speaks to it. #BioPharma #LifeSciences
youtube.com/shorts/3JUyG7tcL…
1
3
398
May 26
Spectral AI receives FDA De Novo Clearance for DeepView Burn
*$MDAI may now begin commercial distribution in the US
finance.yahoo.com/sectors/he…
2
3
140
May 22
CEO Richard Christopher describes where Lexaria has done the most work in the GLP-1 agonist space, combining both injectable API and crushed oral tablets with DehydraTECH.
$LEXX
#OralGLP1 #OralDeliveryTech #GLP1Agonist #GLP1Innovation #MetabolicTherapy
youtube.com/shorts/sG7Xj3Gky…
2
3
319
May 20
Cardiff Oncology filed suit vs Nerviano Medical Sciences, who provides the license for onvansertib
*Disputes claim that $CRDF breached license agreement
*Seeks order for Nerviano to perform according to its agreement
investors.cardiffoncology.co…
2
3
357
May 19
Catch Lexaria's CEO Richard Christopher as he discusses Human Pilot Study #7.
youtube.com/shorts/W9VXzLkYl…
May 19
@LexariaBioCorp receives Independent Review Board approval to begin Human Pilot Study #7.
Compares DehydraTECH formulations of semaglutide against Wegovy tablets.
$LEXX
finance.yahoo.com/sectors/he…
2
3
206
May 17
Chief Executive Officer Brad Carver & Chief Business Officer James Shanahan outline the goals for @syndevrx' clinical trials evaluating evexomostat.
youtu.be/-iC3bWDE6_U
#BioPharma #EmergingBiotech #ClinicalResearch #LifeSciences
2
3
176
May 16
DehydraTECH is used in tablets for the first time. @LexariaBioCorp CEO Richard Christopher discusses GLP-1 Human Study #7 that will evaluate DehydraTECH semaglutide tablet & capsule formulations to Wegovy tablets. $LEXX
youtube.com/shorts/EdLtQmfdk…
#OralGLP1 #GLP1Innovation #MetabolicTherapy
3
4
397
May 15
GeoVax reports 1Q
*Preparation activities ongoing for Ph3 GEO-MVA trial
~CRO selection
~Trial infrastructure activation
*Planned enrollment of 500
*Revs of $1.6mm
*Net loss of $5.3mm
$GOVX
finance.yahoo.com/sectors/he…
2
2
3
270